Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,212,898
+$104,816 QoQ
Shares Held
17,221
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,525
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lantz Financial LLC holds $16,892,877 across 12 Drug Manufacturers - General names. MRK ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,860 | $3,266,054 | |
| 2 | LLY |
ELI LILLY & Co
|
2,003 | $2,402,458 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
17,221 | $2,212,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,595 | $2,096,612 | |
| 5 | ABBV |
AbbVie Inc.
|
8,202 | $2,063,951 | |
| 6 | NVS |
Novartis AG
|
7,596 | $1,190,445 | |
| 7 | PFE |
Pfizer Inc
|
46,747 | $1,125,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,833 | $739,437 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,212,898 | 17,221 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,108,082 | 17,525 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,764,578 | 16,764 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,287,402 | 15,339 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,119,955 | 14,148 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,254,665 | 13,978 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,397,296 | 14,046 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,647,301 | 14,506 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,795,100 | 14,500 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,907,733 | 14,458 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,574,902 | 14,446 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,242,709 | 12,071 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,382,718 | 11,983 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $1,304,554 | 12,262 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,433,474 | 12,920 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,134,544 | 13,174 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,241,644 | 13,619 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,172,166 | 14,286 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,042,380 | 13,601 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,038,696 | 13,829 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,036,518 | 13,328 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $916,600 | 11,890 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $966,221 | 11,812 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,853,518 | 22,345 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,700,255 | 21,987 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,210,023 | 28,724 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||